QQ客服 官方微博 反馈留言

	CRISPR/Cas9-mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse
	Guan, Yuting; Ma, Yanlin; Li, Qi; Sun, Zhenliang; Ma, Lie; Wu, Lijuan; Wang, Liren; Zeng, Li; Shao, Yanjiao; Chen, Yuting
刊名	EMBO MOLECULAR MEDICINE
	2016
卷号	8期号:5
关键词	gene therapy genome editing hemophilia B hemostasis monogenetic disease
ISSN号	1757-4676
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4269006
专题	上海健康医学院
推荐引用方式 GB/T 7714	Guan, Yuting,Ma, Yanlin,Li, Qi,et al. CRISPR/Cas9-mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse[J]. EMBO MOLECULAR MEDICINE,2016,8(5).
APA	Guan, Yuting.,Ma, Yanlin.,Li, Qi.,Sun, Zhenliang.,Ma, Lie.,...&Li, Dali.(2016).CRISPR/Cas9-mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse.EMBO MOLECULAR MEDICINE,8(5).
MLA	Guan, Yuting,et al."CRISPR/Cas9-mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse".EMBO MOLECULAR MEDICINE 8.5(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。